Editorial: RNA-Seq Analysis: Methods, Applications and Challenges

Filippo Geraci, Indrajit Saha, Monica BianchiniFrontiers in Genetics 2020 · DOI · OpenAlex

The Transcriptomic Revolution

RNA-sequencing (RNA-Seq) has fundamentally transformed the landscape of transcriptomic research. By enabling the simultaneous quantification of the entire transcriptome, it has shifted the paradigm from ex ante candidate gene selection to an ex post discovery-driven approach. This technological leap, fueled by decreasing sequencing costs and standardized protocols, has led to the creation of massive, disease-specific datasets through consortia like The Cancer Genome Atlas (TCGA). However, the transition from raw sequencing data to biological insight remains fraught with computational and statistical hurdles.

Overcoming the Analysis Burden

Despite its widespread adoption, RNA-Seq presents a significant "analysis burden." For many life scientists, the traditional UNIX-based command-line environment is a barrier to entry. Furthermore, the statistical models used to identify differentially expressed (DE) genes often rely on assumptions that do not hold for real-world data. For instance, standard binomial distributions frequently fail to account for "underdispersion," leading to potential inaccuracies in identifying significant biological changes.

To address these challenges, recent research has focused on democratizing analysis and refining statistical accuracy. Tools such as RMTA, a scalable workflow for standard processing, and IDEAMEX, a web-based server, have been developed to make transcriptomics accessible to non-experts.

Advancing Single-Cell and Structural Analysis

The frontier of single-cell RNA sequencing (scRNA-seq) introduces even greater complexity. The extreme noise and "dropout" events—where a gene is expressed but not detected—require specialized imputation methods. New algorithms aim to distinguish technical failures from true biological zeros, thereby improving the reliability of cell-type clustering and characterization.

Beyond simple gene expression, RNA-Seq is increasingly used to characterize complex molecules like circular RNAs (circRNAs). Because these molecules form rings by joining 3' and 5' endpoints, they pose unique computational challenges for predicting coding potential. Specialized algorithms are now being developed to handle these non-linear structures, which standard linear models cannot accurately process.

Clinical and Biological Applications

The practical utility of these advanced methods is evident in clinical and biological studies featured in this Research Topic:

  • Oncology: Researchers have identified specific gene panels capable of predicting the onset of Glioblastoma. In lung adenocarcinoma, studies have mapped regulatory cascades where the dysregulation of a single long non-coding RNA (lncRNA) can trigger a sequence of events that halt the cell cycle.
  • Plant Genomics: The versatility of RNA-Seq extends to non-human species, such as studying anthocyanin biosynthesis in plants, demonstrating its broad applicability across the life sciences.

Future Perspectives

While RNA-Seq has moved from a niche technology to a cornerstone of precision medicine, challenges in reproducibility and signal-to-noise ratios persist, particularly at the single-cell level. Future efforts must focus on the seamless integration of transcriptomics with other "omics" layers—genomics and proteomics—to provide a holistic understanding of cellular function. The continued development of user-friendly, statistically robust tools will be essential in navigating the ongoing "data deluge" of the transcriptomic era.

Summary updated

Abstract

RNA-seq has revolutionized the research community approach to studying gene expression. In fact, this technology has opened up the possibility of quantifying the expression level of all genes at once, allowing an ex post (rather than ex ante) selection of candidates that could be interesting for a certain study. The continuous drop in costs and the independence of library preparation protocols from the model species, have convinced the stakeholders to invest in this technology, by creating consortia able to produce large disease-specific datasets that, in turn, fostered transcriptomic research at a population level. Among many others, a virtuous example in this sense is The Cancer Genome Atlas. In a short time RNA-seq has moved from a technology to merely quantify the expression of genes to a powerful tool to: discover new transcripts (via de novo transcriptome assembly), characterize alternative splicing variants or new cell types (through single cell RNA sequencing). Leveraging on RNA-seq for daily diagnostic activities is no longer a dream but a consolidated reality. Although established best practices exist, managing RNA-seq data is not easy. Before sequencing, it is essential to carefully plan library preparation in order to minimize downstream analysis biases. Budget optimization is another important factor. Sequencing multiple samples increases statistical power and reduces undesired side effects due to noise and variability. However, more samples imply higher costs. Multiplexing has proved to be an effective tool to limit the budget without sacrificing the number of samples. DNA barcoding enables combining up to 96 samples into a single line, trading a lower sequencing depth for a higher number of sequenced samples. The downside of this technique is the increased burden of data analysis to achieve the same accuracy that would be achieved with a richer input. Downstream sequencing, fastq data must be validated and processed to distill raw reads into a quantitative measure of gene expression. While validation is somehow a standard procedure, read count depends on the type of RNA (microRNA, etc.) and on the target application. Usually reads are: subjected to adapter removal, aligned against a reference genome, grouped by functional unit (e.g., transcripts, genes, microRNA, etc.), normalized and counted. Subsequent analyses can vary dramatically according to the application. In the simplest setting, the subset of genes responsible for the differences on the phenotype between two populations should be discovered. In other cases, one may want to build the co-expression (or reverse expression) network in order to find interacting genes or a pathway related to a certain phenotype. Other applications involve the discovery of unknown cell types, the organization of cell types in homogeneous families, the identification of new molecules (e.g., new microRNA, long non-coding RNA, etc.), or the annotation of new variants or alternative splicing.
BibTeX
@inproceedings{geraci2020editorial,
  author = {Filippo Geraci and Indrajit Saha and Monica Bianchini},
  title = {{Editorial: RNA-Seq Analysis: Methods, Applications and Challenges}},
  booktitle = {Frontiers in Genetics},
  year = {2020},
  doi = {10.3389/fgene.2020.00220},
}

Loading related content...

Figure